Naohiro Oda
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 13
- Lung Cancer Research Studies 7
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 8
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Chronic Obstructive Pulmonary Disease (COPD) Research 6
-
- Asthma and respiratory diseases 7
-
- Antifungal resistance and susceptibility 4
- Co-authors
- Katsuyuki KiuraYoshinobu MaedaEiki IchiharaKatsuyuki HottaKoji InoueNobuaki OchiDaijiro HaradaNaofumi Hara
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (2 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Naohiro Oda
70 papers receiving 569 citations
Peers
Comparison fields: 5 of 95
- Oncology 258
- Pulmonary and Respiratory Medicine 266
- Immunology 69
- Physiology 84
- Neurology 40
Countries citing papers authored by Naohiro Oda
This map shows the geographic impact of Naohiro Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiro Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiro Oda more than expected).
Fields of papers citing papers by Naohiro Oda
This network shows the impact of papers produced by Naohiro Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiro Oda. The network helps show where Naohiro Oda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naohiro Oda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 43 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 2 | |
| 14 | 2020 | 28 | |
| 15 | 2020 | 18 | |
| 16 | 2019 | 74 | |
| 17 | 2018 | 20 | |
| 18 | 2017 | 4 | |
| 19 | 2017 | 16 | |
| 20 | 2016 | 8 |
About Naohiro Oda
Naohiro Oda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Neurology, having authored 72 papers that have together received 576 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (7 papers), Asthma and respiratory diseases (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Antifungal resistance and susceptibility (4 papers). The work is most often cited by research in Oncology (258 citations), Pulmonary and Respiratory Medicine (266 citations) and Immunology (69 citations). Naohiro Oda has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Katsuyuki Kiura, Yoshinobu Maeda, Eiki Ichihara, Katsuyuki Hotta, Koji Inoue, Nobuaki Ochi, Daijiro Harada, Naofumi Hara, Shinobu Hosokawa and Nobuaki Miyahara. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.